Your browser doesn't support javascript.
loading
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism.
Filipe, Elysse C; Velayuthar, Sipiththa; Philp, Ashleigh; Nobis, Max; Latham, Sharissa L; Parker, Amelia L; Murphy, Kendelle J; Wyllie, Kaitlin; Major, Gretel S; Contreras, Osvaldo; Mok, Ellie T Y; Enriquez, Ronaldo F; McGowan, Suzanne; Feher, Kristen; Quek, Lake-Ee; Hancock, Sarah E; Yam, Michelle; Tran, Emmi; Setargew, Yordanos F I; Skhinas, Joanna N; Chitty, Jessica L; Phimmachanh, Monica; Han, Jeremy Z R; Cadell, Antonia L; Papanicolaou, Michael; Mahmodi, Hadi; Kiedik, Beata; Junankar, Simon; Ross, Samuel E; Lam, Natasha; Coulson, Rhiannon; Yang, Jessica; Zaratzian, Anaiis; Da Silva, Andrew M; Tayao, Michael; Chin, Ian L; Cazet, Aurélie; Kansara, Maya; Segara, Davendra; Parker, Andrew; Hoy, Andrew J; Harvey, Richard P; Bogdanovic, Ozren; Timpson, Paul; Croucher, David R; Lim, Elgene; Swarbrick, Alexander; Holst, Jeff; Turner, Nigel; Choi, Yu Suk.
Affiliation
  • Filipe EC; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Velayuthar S; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Philp A; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Nobis M; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Latham SL; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Parker AL; Centenary Institute, Camperdown, NSW, 2050, Australia.
  • Murphy KJ; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Wyllie K; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Major GS; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Contreras O; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Mok ETY; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Enriquez RF; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • McGowan S; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Feher K; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Quek LE; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Hancock SE; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Yam M; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Tran E; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Setargew YFI; Victor Chang Cardiac Research Institute, Darlinghurst, NSW, 2010, Australia.
  • Skhinas JN; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Chitty JL; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Phimmachanh M; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Han JZR; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Cadell AL; South Australian immunoGENomics Cancer Institute (SAiGENCI), Adelaide, SA, 5005, Australia.
  • Papanicolaou M; School of Mathematics and Statistics, Charles Perkins Centre, University of Sydney, Sydney, 2050, Australia.
  • Mahmodi H; Victor Chang Cardiac Research Institute, Darlinghurst, NSW, 2010, Australia.
  • Kiedik B; School of Biomedical Sciences, UNSW Sydney, Sydney, 2033, Australia.
  • Junankar S; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Ross SE; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Lam N; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Coulson R; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Yang J; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Zaratzian A; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Da Silva AM; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Tayao M; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Chin IL; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Cazet A; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Kansara M; School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia.
  • Segara D; School of Mathematical and Physical Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia.
  • Parker A; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Hoy AJ; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Harvey RP; School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW Sydney, Sydney, 2010, Australia.
  • Bogdanovic O; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Timpson P; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Croucher DR; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Lim E; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Swarbrick A; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Holst J; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Turner N; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia.
  • Choi YS; School of Human Sciences, University of Western Australia, Crawley, WA, 6009, Australia.
Adv Sci (Weinh) ; 11(23): e2307963, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38602451
ABSTRACT
In recent decades, the role of tumor biomechanics on cancer cell behavior at the primary site has been increasingly appreciated. However, the effect of primary tumor biomechanics on the latter stages of the metastatic cascade, such as metastatic seeding of secondary sites and outgrowth remains underappreciated. This work sought to address this in the context of triple negative breast cancer (TNBC), a cancer type known to aggressively disseminate at all stages of disease progression. Using mechanically tuneable model systems, mimicking the range of stiffness's typically found within breast tumors, it is found that, contrary to expectations, cancer cells exposed to softer microenvironments are more able to colonize secondary tissues. It is shown that heightened cell survival is driven by enhanced metabolism of fatty acids within TNBC cells exposed to softer microenvironments. It is demonstrated that uncoupling cellular mechanosensing through integrin ß1 blocking antibody effectively causes stiff primed TNBC cells to behave like their soft counterparts, both in vitro and in vivo. This work is the first to show that softer tumor microenvironments may be contributing to changes in disease outcome by imprinting on TNBC cells a greater metabolic flexibility and conferring discrete cell survival advantages.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids / Tumor Microenvironment / Triple Negative Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Adv Sci (Weinh) Year: 2024 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids / Tumor Microenvironment / Triple Negative Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Adv Sci (Weinh) Year: 2024 Document type: Article Affiliation country: Australia